Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Quantum Biopharma Ltd Cls B Subordinate Voting S (QNTM.CN)

Quantum Biopharma Ltd Cls B Subordinate Voting S (QNTM.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 47,712
  • Shares Outstanding, K 3,817
  • Annual Sales, $ 0 K
  • Annual Income, $ -14,203 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.18
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.93

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.7000 +16.82%
on 11/07/25
22.7500 -45.05%
on 10/15/25
-7.9000 (-38.73%)
since 10/10/25
3-Month
10.7000 +16.82%
on 11/07/25
43.0000 -70.93%
on 08/11/25
-27.3500 (-68.63%)
since 08/08/25
52-Week
3.9000 +220.51%
on 12/20/24
52.0000 -75.96%
on 06/20/25
+4.7000 (+60.26%)
since 11/08/24

Most Recent Stories

More News
Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern’ Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio

TORONTO, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“ Quantum BioPharma ” or the “ Company ”), is pleased to announce its financial and operational...

QNTM : 8.21 (-2.21%)
QNTM.CN : 12.5000 (unch)
Quantum BioPharma Ltd. Provides Corporate Update

TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K9A) (“ Quantum ” or the “ Company ”), a biopharmaceutical company dedicated to building a...

QNTM : 8.21 (-2.21%)
QNTM.CN : 12.5000 (unch)
Quantum BioPharma Ltd. Announces Corporate Updates

Toronto, Ontario--(Newsfile Corp. - October 29, 2025) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) (Upstream: QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company...

QNTM.CN : 12.5000 (unch)
Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar for its Disruptive Beverage Innovation that Speeds Alcohol Metabolism, Reduces Symptoms of Intoxication

TORONTO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“ Quantum BioPharma ”), a biopharmaceutical company dedicated to building...

QNTM : 8.21 (-2.21%)
QNTM.CN : 12.5000 (unch)
Quantum BioPharma Ltd. Announces Expiration of All Warrants Held by Hedge Funds and Re-Iterates October 27, 2025, Record Date for the Distribution of a Special Dividend

TORONTO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“ Quantum BioPharma ” or the “ Company ”), a biopharmaceutical company...

QNTM : 8.21 (-2.21%)
QNTM.CN : 12.5000 (unch)
Quantum BioPharma Ltd. Responds to Vague and Misleading Allegations by The Schall Law Firm and DJS Law Group

TORONTO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“ Quantum BioPharma ” or the “ Company ”), a biopharmaceutical company...

QNTM : 8.21 (-2.21%)
QNTM.CN : 12.5000 (unch)
Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

TORONTO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“ Quantum BioPharma ” or the “ Company ”), a biopharmaceutical company...

QNTM : 8.21 (-2.21%)
QNTM.CN : 12.5000 (unch)
From Lab Bench to Blockchain: How Biotech is Reinventing Funding

The %Biotech field is no stranger to scientific breakthroughs, but combining novel therapeutic platforms with progressive treasury strategies is relatively new, and potentially disruptive. Many companies,...

ETHZ : 17.91 (-1.43%)
^ETHUSD : 3,519.398 (-0.46%)
QNTM : 8.21 (-2.21%)
QNTM.CN : 12.5000 (unch)
PPCB : 0.8826 (-2.15%)
^ETHUSDT : 3,518.734 (-0.52%)
BTCS : 2.97 (-4.81%)
^ETHBTC : 0.033701 (+0.44%)
Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case

TORONTO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“ Quantum BioPharma ” or the “ Company ”), a biopharmaceutical company dedicated to building...

QNTM : 8.21 (-2.21%)
QNTM.CN : 12.5000 (unch)
Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial

TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“ Quantum BioPharma ” or the “ Company ”), a biopharmaceutical company...

QNTM : 8.21 (-2.21%)
QNTM.CN : 12.5000 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Relative Strength is below 30%. The market is in oversold territory. Watch for a potential trend reversal.

See More Share

Business Summary

Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its...

See More

Key Turning Points

3rd Resistance Point 12.5000
2nd Resistance Point 12.5000
1st Resistance Point 12.5000
Last Price 12.5000
1st Support Level 12.5000
2nd Support Level 12.5000
3rd Support Level 12.5000

See More

52-Week High 52.0000
Fibonacci 61.8% 33.6258
Fibonacci 50% 27.9500
Fibonacci 38.2% 22.2742
Last Price 12.5000
52-Week Low 3.9000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar